| The Wnt signaling pathway in cancer Y Duchartre, YM Kim, M Kahn Critical reviews in oncology/hematology 99, 141-149, 2016 | 551 | 2016 |
| A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity S Khan, X Zhang, D Lv, Q Zhang, Y He, P Zhang, X Liu, D Thummuri, ... Nature medicine 25 (12), 1938-1947, 2019 | 435 | 2019 |
| Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cells MY Mapara, YM Kim, SP Wang, R Bronson, DH Sachs, M Sykes Blood, The Journal of the American Society of Hematology 100 (5), 1903-1909, 2002 | 298 | 2002 |
| Wnt/catenin signaling in adult stem cell physiology and disease A Ring, YM Kim, M Kahn Stem Cell Reviews and Reports 10, 512-525, 2014 | 242 | 2014 |
| BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition C Duy, C Hurtz, S Shojaee, L Cerchietti, H Geng, S Swaminathan, ... Nature 473 (7347), 384-388, 2011 | 216 | 2011 |
| The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia L Klemm, C Duy, I Iacobucci, S Kuchen, G von Levetzow, N Feldhahn, ... Cancer cell 16 (3), 232-245, 2009 | 198 | 2009 |
| BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia C Hurtz, K Hatzi, L Cerchietti, M Braig, E Park, Y Kim, S Herzog, ... Journal of Experimental Medicine 208 (11), 2163-2174, 2011 | 193 | 2011 |
| Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720 YM Kim, T Sachs, W Asavaroengchai, R Bronson, M Sykes The Journal of clinical investigation 111 (5), 659-669, 2003 | 181 | 2003 |
| Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia EJ Gang, YT Hsieh, J Pham, Y Zhao, C Nguyen, S Huantes, E Park, ... Oncogene 33 (17), 2169-2178, 2014 | 174 | 2014 |
| Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function D Trageser, I Iacobucci, R Nahar, C Duy, G von Levetzow, L Klemm, ... Journal of Experimental Medicine 206 (8), 1739-1753, 2009 | 151 | 2009 |
| MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment MC Stubbs, YM Kim, AV Krivtsov, RD Wright, Z Feng, J Agarwal, AL Kung, ... Leukemia 22 (1), 66-77, 2008 | 150 | 2008 |
| CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression K Fousek, J Watanabe, SK Joseph, A George, X An, TT Byrd, JS Morris, ... Leukemia 35 (1), 75-89, 2021 | 147 | 2021 |
| Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy YT Hsieh, EJ Gang, H Geng, E Park, S Huantes, D Chudziak, K Dauber, ... Blood, The Journal of the American Society of Hematology 121 (10), 1814-1818, 2013 | 137 | 2013 |
| Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia E Park, EJ Gang, YT Hsieh, P Schaefer, S Chae, L Klemm, S Huantes, ... Blood, The Journal of the American Society of Hematology 118 (8), 2191-2199, 2011 | 131 | 2011 |
| Callosotomy for epilepsy after West syndrome JM Pinard, O Delalande, C Chiron, C Soufflet, P Plouin, Y Kim, O Dulac Epilepsia 40 (12), 1727-1734, 1999 | 119 | 1999 |
| Minimal residual disease detection in acute lymphoblastic leukemia A Kruse, N Abdel-Azim, HN Kim, Y Ruan, V Phan, H Ogana, W Wang, ... International journal of molecular sciences 21 (3), 1054, 2020 | 109 | 2020 |
| Role of integrin alpha4 in drug resistance of leukemia S Shishido, H Bönig, YM Kim Frontiers in oncology 4, 99, 2014 | 106 | 2014 |
| Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR MY Mapara, C Leng, YM Kim, R Bronson, A Lokshin, A Luster, M Sykes Biology of Blood and Marrow Transplantation 12 (6), 623-634, 2006 | 104 | 2006 |
| Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for … MT Rubio, YM Kim, T Sachs, M Mapara, G Zhao, M Sykes Blood 102 (6), 2300-2307, 2003 | 100 | 2003 |
| Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia … MY Mapara, YM Kim, J Marx, M Sykes Transplantation 76 (2), 297-305, 2003 | 78 | 2003 |
